Description

Ethyl 3,5-Dimethyl-1-(5-[(4-Toluidinocarbonyl)Amino]-2-Pyridinyl)-1H-Pyrazole-4-Carboxylate is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in research and development pipelines. It is primarily sought by pharmaceutical manufacturers and contract research organizations (CROs) engaged in the development of new therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of target drug molecules, especially within medicinal chemistry research.
• API Development: Used in the research and process development stages for creating new active pharmaceutical ingredients with potential therapeutic applications.
• Chemical Synthesis Research: Acts as a specialized reagent in academic and industrial laboratories for constructing complex pyrazole and pyridine-based heterocycles.
• Preclinical Studies: Supplied in high purity for use in the early-stage pharmacological and toxicological evaluation of new chemical entities.
• Process Chemistry Optimization: Utilized by process chemists to develop and scale up efficient, cost-effective synthetic routes for candidate drugs.

Basic Information

Product Name	Ethyl 3,5-Dimethyl-1-(5-[(4-Toluidinocarbonyl)Amino]-2-Pyridinyl)-1H-Pyrazole-4-Carboxylate
CAS No.	477712-91-7
Molecular Formula	C21H23N5O3
Molecular Weight	393.44 g/mol
Synonyms	Ethyl 3,5-dimethyl-1-{5-[(4-methylphenyl)carbamoyl]amino-2-pyridinyl}-1H-pyrazole-4-carboxylate; 1H-Pyrazole-4-carboxylic acid, 3,5-dimethyl-1-[5-[[[(4-methylphenyl)amino]carbonyl]amino]-2-pyridinyl]-, ethyl ester; UNII-9V6A6U6G4B; 9V6A6U6G4B; Ethyl 3,5-dimethyl-1-(5-((p-tolylcarbamoyl)amino)pyridin-2-yl)-1H-pyrazole-4-carboxylate
EINECS	Contact for details

Quality Control

Our Ethyl 3,5-Dimethyl-1-(5-[(4-Toluidinocarbonyl)Amino]-2-Pyridinyl)-1H-Pyrazole-4-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect the compound from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.